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 B iomedical research, as the term suggests, has always been engaged in fundamental biological discoveries that lead to practical applications into human health as its fi nal 
goal. Over the last decades much has been written about the 
rapid transformation of basic sciences, yet the progression and 
implementation of these new ideas into the marketplace continues 
to occur at a glacial pace. To overcome this “translational” gap, 
there have been calls for new methodologies, new mechanisms 
of funding research, and the need to create multidisciplinary 
research teams with expertise in “translational sciences.” Th is has 
resulted in the establishment the National Center for Advancing 
Translational Sciences (NCATS) within the National Institutes 
of Health, and funding of 61 Clinical and Translational Science 
Awards (CTSAs) to establish “integrated homes” across academic 
medical centers for translational research. 
 Partly due to increasing societal and consumer demands and 
tightening funding constraints, there is now clear emphasis on 
translational research in all areas of biomedical research. Such a 
paradigm change has forced academic research establishments into 
rethinking about institutional resources, effi  ciency of processes, and 
wholesale transformation of institutional environments to foster 
translational research. However, this is not a simple or linear process 
that can be easily accomplished within academic environments. 
For example, the series of translational steps that take a small 
molecule to market are quite distinct from similar steps required 
to take a device to patients, which is yet diff erent from the steps that 
make eff ective implementation of a practice innovation into the 
broader community possible. Also, since translating fundamental 
discoveries into practice involves a series of complex scientifi c, 
regulatory, commercial, and fi nancial steps, and a coordinated 
activity of a wide range of experts working in teams, it has created 
a need for establishing a systematic fi eld of knowledge. 
 Despite this increased emphasis on translation, the formal 
field of “translational sciences” is still relatively recent and 
evolving. Also, the term translational sciences is a fi eld that 
has started to take on somewhat diff ering meanings to groups 
engaged in moving diff erent types of discoveries into practice, 
and has created signifi cant confusion in its practitioners, leading 
to fragmentation of eff orts to advance its mission. Th is problem is 
particularly acute when it comes to training young investigators 
and students, i.e., the translational research workforce of the 
future. Th us, a clear and immediate task from the point of view 
of the Association of Clinical Translational Sciences (ACTS) is 
to clearly defi ne a comprehensive “worldview” of translational 
sciences and catalogue its diverse practitioners and stakeholders 
for inclusion into its broad tent. Such an eff ort would not only 
help develop unique programs within ACTS and other biomedical 
research societies, provide career development resources for future 
practitioners, streamline advocacy for translational research 
through multiple stakeholders, and also increase the readership 
and contributor base for the CTS and similar journals. Th erefore, 
the leadership of ACTS is rolling out a series of strategic planning 
sessions, focus group meetings, and broad surveys to better defi ne 
the fi eld “translational sciences” and its “membership” over the 
next few months. 
 While there is general acceptance of the need to transform 
our research processes and training of future researchers, there 
are still many challenges to making these transformations at the 
level of individual academic medical centers. Th e majority of 
the research faculty at academic medical centers, although very 
interested in and willing to embrace translational research, are 
housed in environments where they are recognized for being 
experts in very focused areas of discovery and supported by 
traditional R01 grant mechanisms which put a premium on 
deep expertise. Th e institutional success metrics (publications, 
recognition by societies, invitations to panels, etc.) further keep 
them discouraged from deviating from the current model. 
Academic researchers need a “permissive” local habitat for 
translational research, and much of this responsibility falls on 
university and academic center leadership where there is a paucity 
of best practices to guide the leadership. Local transformation 
will need an institutional “microenvironment” that will not kill 
such eff orts with disincentives based on rigid systems of reward, 
promotion, and tenure processes. 
 One approach that is being explored by some institutions 
is populating increasing numbers of “clinician-scientists” who 
could create a fulcrum of change within clinical departments, and 
begin to bridge collaborations with basic science departments . 
Increasing such “cross-cutting” faculty group will naturally create 
a tipping point when rapid cultural transformation can occur. I 
am familiar with one great example of such an eff ort with the 
Physician-Scientist Initiative (PSI) being implemented at Indiana 
University. Th e PSI program was funded by a $60 million grant 
from the Lilly Endowment under the leadership of the dean of the 
school of medicine, and managed by committee of translational 
research leaders that is chaired by the executive associate dean 
for research. Th e initiative provides start-up and recruitment 
dollars to any clinical department that is interested in bringing 
in clinician-scientists, defi ned broadly as those with clinical 
training who devote substantive eff ort to research anywhere along 
the entire spectrum of biomedical inquiry, ranging from basic 
sciences to patient outcomes and policy. Th e requirements are 
that such faculty need to be dually recruited with a basic science 
department, and are incentivized upon arrival to create new 
cross-disciplinary research programs and grants. Th e program 
has been extremely popular with clinical department chairs and 
has so far recruited nearly 20 such researchers. It has created 
new programs ranging from bone biology, cancer therapeutics, 
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cardiac genetics, and pediatric intensive care to biomedical 
informatics, all engaging basic science departments ranging from 
anatomy to computer sciences. While the long-term benefi ts of 
the PSI program are still being evaluated, it has already created 
a culture of communication, collaboration, and mutual respect 
and dependence between the clinical and basic sciences faculty 
that is new and exciting. 
 I believe, for “translational sciences” to permanently take 
root within academic medical centers, we need to make an all-
out eff ort to changing our institutional microenvironments that 
complement the eff orts at the national level by agencies like the 
NIH and NCATs, and societies like ACTS. Investing for the future 
should include a focus on developing a new generation of clinician 
scientists that are able to lead these initiatives. CTS
